This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Premarket Roundup: Insurers, Acorda Therapeutics


Among the premarket stories for Thursday, Oct. 15, from AP Financial News:

¿ An improving financial outlook for property and casualty insurers means they may not be able to raise rates on customers and may have to drop prices, said Keefe Bruyette & Woods, downgrading shares of Travelers Cos. and two other insurers.

¿ Shares of Acorda Therapeutics Inc. skyrocketed in premarket trading Thursday after a Food and Drug Administration panel released a positive review of Acorda's drug candidate Fampridine-SR, increasing the chances the multiple sclerosis treatment will be approved for sale.

¿ Shares of Host Hotels & Resorts Inc. dropped Thursday after a Baird analyst cut his rating on the lodging real estate investment trust, cautioning investors that a recovery in the hotel sector is further away than a recent rally in Host's shares suggests.

¿ Bill Barrett Corp. shares are positioned to grow, said an analyst Thursday as he upgraded the natural gas and oil producer's stock.

¿ Chicago Bridge & Iron Company NV, an energy-infrastructure construction company, will benefit from a natural gas project in Australia, could potentially increase its earnings on contract awards and its share value has room to grow, an analyst said Thursday.

¿ An analyst downgraded Granite Construction Inc. Thursday, saying the contractor and producer of construction materials could feel the impact of reduced spending on public works in the next six months to a year.
Copyright 2009 Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
ACOR $27.34 -5.43%
BBG $8.57 -8.34%
CBI $40.05 -2.34%
GVA $45.56 -1.00%
HST $15.82 -0.75%


Chart of I:DJI
DOW 17,830.76 -210.79 -1.17%
S&P 500 2,075.81 -19.34 -0.92%
NASDAQ 4,805.2910 -57.85 -1.19%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs